老年人脑梗塞后认知功能障碍的危险因素:一项回顾性研究
Fanyuan Ma1,2, Qian Zhang2, Jinke Li2
1Department of Geriatrics, Tangdu Hospital, Air Force Medical University, Xi'an, China.
BMC neurology
|February 20, 2024
概括
2型糖尿病 (T2D) 和生活在农村地区增加了中风后认知功能障碍的风险. 较低的直接胆红素水平与脑梗塞后更好的认知功能有关.
科学领域:
- 神经学 神经学
- 内分泌学 在内分泌学.
- 老年病的医生 老年病的医生
背景情况:
- 脑梗塞后认知功能障碍 (PCICD) 是中风后的一个重要并发症.
- 2型糖尿病 (T2D) 是众所周知的各种神经疾病的风险因素,但其在PCICD中的特定作用需要进一步阐明.
- 确定PCICD可靠的预测因子对于及时干预和改善患者结果至关重要.
研究的目的:
- 调查T2D和PCICD之间的关联.
- 开发和验证PCICD的新型风险预测模型.
- 确定脑梗塞后认知功能障碍的关键临床和生化预测因素.
主要方法:
- 分析了353名住院患者的队列,这些患者因脑梗塞住院治疗.
- 认知功能被评估使用迷你精神状态检查 (MMSE).
- 采用多变量逻辑回归来确定PCICD的独立预测因子,考虑人口统计,临床和流体生物标记数据.
主要成果:
- 生活在农村地区 (OR=1.976),T2D (OR=2.125) 和更严重的依赖 (巴特尔指数) 独立地与PCICD风险增加有关.
- 较低的血清直接胆红素水平 (OR=0.388) 与PCICD风险降低有显著联系.
- 鉴定出来的因素形成了一个具有PCICD最佳预测效率的模型.
结论:
- 这项研究提供了一个实用的模型,用于识别患有PCICD风险的患者.
- 二型糖尿病和农村生活是中风后认知能力下降的重要危险因素.
- 血清直接胆红素度的下降可能成为脑梗塞后认知功能的保护因素.
更多相关视频
09:11Performing Permanent Distal Middle Cerebral with Common Carotid Artery Occlusion in Aged Rats to Study Cortical Ischemia with Sustained Disability
Published on: February 23, 2016
21.6K
10:13Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
Published on: February 14, 2014
13.7K
相关概念视频
01:30Cognitive Development During Adulthood
109
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
109
01:14Role of Cerebellum and Prefrontal Cortex in Memory
430
The cerebellum, while traditionally associated with motor control, also plays a crucial role in memory, particularly in procedural memory, which involves learning motor tasks that become automatic through repetition. For example, studies have shown that when the cerebellum is damaged, individuals or animals lose the ability to learn conditioned motor responses, such as the conditioned eye-blink response in classical conditioning experiments with rabbits. This study demonstrates the...
430
01:30Dementia
113
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
113
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
125
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
125
01:26Alzheimer's Disease: Overview
484
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
484